Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran

• Egile Nagusiak: Abdollahi Mohammad (Egilea), Majdzadeh Reza (Egilea), Kebriaeezadeh Abbas (Egilea), Nikfar Shekoufeh (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2005-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Pharmaceuticals have made an important contribution to global reductions in morbidity and mortality. To help save lives and improve health, it is important to be sure about equity to access to drugs, drug efficacy, quality and safety...